|
|
Technology The Need Oxygen Free Radicals and their analogues (collectively known as Reactive Oxygen Species (ROS)) are essential for effective metabolic activity in all living organisms. However, a high ROS concentration may cause excessive oxidation that is damaging to many biological pathways. The body tries to maintain a balance between ROS and its antioxidant defenses to ensure healthy physiology. When this equilibrium becomes unbalanced, the body's physiological response/activity may be adversely affected, leading to disease. Medical research has conclusively shown that Oxidative Stress is a major factor in diseases such as:
The Solution
The TCL Analyzer directly and rapidly analyzes oxidizability without the need for any reagents. Its advantages over existing methods include lower cost, simpler assay, no need for a skilled technician less technician time required, and an output that is both digital and predictive. A patent for TCL Analyzer (method and apparatus) has been granted in USA, Japan, Australia, China, Russia and Israel. More approvals are expected. Applications Currently, in spite of the importance of investigating oxidative stress, many studies are limited in number of samples due to the complexity of the existing assay methods. The TCL analyzer opens new horizons for both research and clinical applications due to its easy operation, fast response, and no need for skilled personnel. Over the next few years Oxidative Stress measurement will develop from their current research applications to active use in the clinical diagnostics arena. Based on the constant need for an effective, rapid and user-friendly tool to gauge free radical activity in their biological samples TCL is already showing promise as a technique in:
A clinical study, held by Lumitest shows very promising indication for the use of TCL test as a prognostic and diagnostic biomarker for severe CHF patients. According to the results - TCL may be used as a risk stratification tool for patients with HF. In patients who are discharged from the hospital after ADHF, it may be used as a general prognostic marker and as a predictor for a near HF admission (1-4 months) and possibly will be able to predict a HF admission in the next two weeks. |
| | Company profile | | | Technology | | | Business Opportunities | | | Articles | | | Contact Us | | | Home | |